A bacteriophage-based platform for rapid trace detection of proteases

Area of Science:

• Biotechnology
• Analytical Chemistry
• Microbiology

Background:

• Sensitive, rapid, and inexpensive protease activity assays are crucial for clinical diagnostics.
• Detecting highly potent bacterial toxins from Clostridium botulinum and Bacillus anthracis requires exceptional sensitivity.

Purpose of the Study:

• To develop an inexpensive and sensitive assay platform for activity-based protease quantification.
• To apply this platform for the detection of bacterial toxins, specifically botulinum neurotoxin (BoNT) and anthrax lethal factor.

Main Methods:

• Utilized filamentous bacteriophage as an exponentially amplifiable reporter system.
• Assay based on specific cleavage of bacteriophage from a solid support.
• Quantification of cleaved bacteriophage via infectivity or quantitative PCR.

Main Results:

• Demonstrated detection of botulinum neurotoxin (BoNT) serotypes A and B.
• Successfully detected anthrax lethal factor.
• Achieved picomolar range detection limits, with a limit of detection of 2 pM for BoNT/A under optimized conditions.

Conclusions:

• The developed bacteriophage-based assay is inexpensive, sensitive, and rapid.
• The platform is effective for activity-based protease quantification.
• This assay shows promise for the sensitive detection of dangerous bacterial toxins in clinical diagnostics.